✦ LIBER ✦

Splenectomy for hematologic depression in lymphocytic lymphoma and leukemia

✍ Scribed by Stevan Adler; Leon Stutzman; Joseph E. Sokal; Arnold Mittelman

Publisher: John Wiley and Sons
Year: 1975
Tongue: English
Weight: 678 KB
Volume: 35
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197502)35:2<521::aid-cncr2820350234>3.0.co;2-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Splenectomy for thrombocytopenia in chro

Splenectomy for thrombocytopenia in chronic lymphocytic leukemia

✍ Stuart A. Merl; Michael E. Theodorakis; Jack Goldberg; Arlan J. Gottlieb 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB 👁 2 views

Splenectomy for end-stage chronic lympho

Splenectomy for end-stage chronic lymphocytic leukemia

✍ Richard S. Stein; Douglas Weikert; John P. Greer; John M. Flexner 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB 👁 2 views

The value of splenectomy in chronic lymp

The value of splenectomy in chronic lymphocytic leukemia

✍ J. R. Delpero; J. A. Gastaut; Y. P. Letreut; A. Caamano; N. Mathieu-Tubiana; D. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 584 KB

Splenectomy for hypersplenism in chronic

Splenectomy for hypersplenism in chronic lymphocytic leukaemia and malignant non-Hodgkin's lymphoma

✍ Professor J. R. Delpero; G. Houvenaeghel; J. A. Gastaut; P. Orsoni; J. L. Blache 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 739 KB

Corticosteroid therapy for lymphomas and

Corticosteroid therapy for lymphomas and chronic lymphocytic leukemia

✍ Dr. Ediz Z. Ezdinli; Leon Stutzman; C. William Aungst; Dincer Firat 📂 Article 📅 1969 🏛 John Wiley and Sons 🌐 English ⚖ 837 KB

Spleen irradiation in chronic lymphocyti

Spleen irradiation in chronic lymphocytic leukemia (CLL): Palliation in patients unfit for splenectomy

✍ Kristian Aabo; Sven Walbom-Jorgensen 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 2 views

In 22 patients with CLL given 30 courses of spleen irradiation, 23 responses were observed (77%, 95% confidence limits, 58-90%). Response was defined as reduction in palpable spleen size accompanied by relief of symptoms (pain, abdominal discomfort, and sweating) or improvement in hypersequestration